Tilray launches new cannabis education platform
The WeCare-MedicalCannabis platform is now available for patients and healthcare professionals
24 results for “tilray”
The WeCare-MedicalCannabis platform is now available for patients and healthcare professionals
Global cannabis producer, Tilray has announced it will begin to import and distribute medical cannabis products in the UK next month. A new agreement announced this week will allow doctors […]
Via Business of Cannabis Denmark’s six-year medical cannabis pilot scheme could soon be expanded into a fully legalised market, following a surprise announcement from the government last week. The Danish […]
Via Business of Cannabis Portugal’s cannabis regulator has approved three new cannabis preparations for its medical cannabis programme, marking the first expansion since 2021. Since voting to legalise medical cannabis […]
A cannabis charity raised over €400,000 to make the trial possible.
The UK saw the second highest number of clinical trials on cannabinoids in the last decade, the majority linked to GW Pharmaceuticals.
Researchers say THC potency is not necessarily indicative of better quality, or a more positive experience.
The company’s flower-based cannabis products have increased in price by 50p per gram.
60 per cent of respondents also said they would consider cannabis as an alternative to traditional medicine.
Support for legalisation was also up 16 per cent compared to data from 2010.
Grow Pharma has set out its plans for the year ahead.
CannEpil is the first drug available through the programme but has yet to be prescribed
Don’t miss the upcoming informative webinars on medical cannabis next month
Alex Fraser, patient access lead at Grow Pharma on the importance of peer-to-peer learning.
Politicians, activists, campaigners and patients react to the news that CannEpil will be the first drug available through MCAP
Elite Growth is on a mission to transform the global medical cannabis market. Its team of experts and industry veterans reveal how.
Demand for medical cannabis in Luxembourg was three times higher in 2020 than in 2019.
AltoVerde wants to shake things up in the industry which it believes has gone from counter-culture to corporate.
The UK has shown signs of following North America’s footsteps as it faces a growing issue of opioid dependency.
More research is suggesting that cannabis extracts could play a role in the treatment and prevention of Covid-19 – which could be a boon for those in the beverage space. […]
Global cannabis distributor, Halo Collective, is expanding its importation programme to bring flower based products to patients in the UK. The Oregon-based company will now import flower based medical cannabis […]
After seeing how cannabis helped her mum’s battle with cancer, Alexandra Carstea is leading the campaign for medical legalisation in Romania in her memory. Next week, lawyer and mum-of-one, Alexandra […]
Supplies of flower-based medical cannabis products available in the UK are continuing to grow, as the LYPHE Group imports Northern Green Canada into the market. LYPHE Group, one of the […]